Momenta Pharmaceuticals, Inc. (MNTA)

[floblu14]

Thanks, Boing -

Further info on new patent application

METHODS RELATED TO BIOLOGICS 2017-03-16

This disclosure provides, in part, methods and compositions sufficient to make and test products that qualify as tocilizumab, e.g., that are interchangeable versions of Actemra®.

https://worldwide.espacenet.com/publicationDetails/description?CC=US&NR=2017074890A1&KC=A1&FT=D&ND=3&date=20170316&DB=EPODOC&locale=en_EP

Roche gets boost from FDA in bid to expand uses for Actemra

The U.S. Food and Drug Administration has granted breakthrough status to Roche's rheumatoid arthritis medication Actemra for giant cell arteritis, the Swiss drugmaker said, a step which could help it broaden applications for the medicine.

Giant cell arteritis is a chronic, potentially life-threatening autoimmune condition caused by inflammation of large and medium-sized arteries, most often in the head but also in the aorta and its branches.

It generally affects people over the age of 50.

Actemra is Roche's fifth-best-selling medicine, with first-half 2016 sales rising 17 percent to 814 million Swiss francs ($833 million) as doctors prescribed it for rheumatoid arthritis and juvenile idiopathic arthritis.

http://www.reuters.com/article/us-roche-actemra-idUSKCN1250C8